Molecular Imaging

SNMMI notes pros and cons in CMS final 2026 OPPS rule

By AuntMinnie.com staff writers

The final rule includes two new Healthcare Common Procedure Coding System (HCPCS) codes relevant to nuclear medicine.

November 26, 2025

New SPECT/CT tracer visualizes distribution of ALS drug

By Will Morton

Tofersen has been approved for treating amyotrophic lateral sclerosis (ALS), but its regional brain uptake is not fully understood.

November 25, 2025

ConcertAI launches new reimbursement tool

By AuntMinnie.com staff writers

AI-powered platform tailored to payer requirements for reimbursable imaging biomarkers.

November 21, 2025

UCLA to launch department of nuclear medicine and theranostics

By AuntMinnie.com staff writers

The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.

November 19, 2025

Cardiology network extends adoption of GEHC's Flyrcado

By AuntMinnie.com staff writers

After a successful pilot, Cardiovascular Associates of America plans to expand adoption of GEHC's radiotracer Flyrcado.

November 19, 2025

Stress coping may protect against cognitive decline

By Will Morton

Adaptive coping was associated with better cognitive trajectories, independent of amyloid and tau PET brain pathology.

November 18, 2025

Siemens Healthineers rebrands radiopharmaceutical companies

By AuntMinnie.com staff writers

Siemens Healthineers has rebranded PETNet Solutions and AdAcAp Molecular Imaging as its radiopharma business segment.

November 18, 2025

ITM secures U.S. FDA fast-track designation for kidney cancer PET agent

By AuntMinnie.com staff writers

Along with the radiotherapeutic compound ITM-91, the two make up a peptide-based theranostic pair.

November 17, 2025

IAEA recommends global adoption of PSMA-PET

By Will Morton

The finding follows a trial involving 775 men with high-risk prostate cancer across 11 countries with varied income levels.

November 14, 2025

SNMMI issues position paper on RPT

By AuntMinnie.com staff writers

Radiopharmaceutical therapy (RPT) is a rapidly growing form of precision cancer treatment.

November 12, 2025

PSMA-PET effective for initial staging of prostate cancer

By Will Morton

Upfront PSMA-PET/CT has a significant impact on treatment decision-making in men with suspected disease.

November 10, 2025

PSMA-PET visualizes treatment response in liver cancer

By Will Morton

Three radiologists reading PSMA-PET scans agreed almost perfectly on how patients responded to treatment.

November 6, 2025

Page 1 of 617

Next Page